MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1

Cell Biology International

Volumn 40, Issue 6, 2016, Pages 621-628

  Li, Ying Jie ^a   Ping, Chen ^a   Tang, Jian ^a   Zhang, Wen ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Migration; miR 455; Non small cell lung cancer; ZEB1

Indexed keywords

MICRORNA; MICRORNA 455; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN455 MICRORNA, HUMAN; ZEB1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; TUMOR INVASION; UPREGULATION; ZEB1 GENE; BIOSYNTHESIS; CELL MOTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; UP-REGULATION; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84961784350     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10584     Document Type: Article

References (30)

1. Barbachano A, Fernandez-Barral A, Pereira F, Segura MF, Ordonez-Moran P, Carrillo-de Santa Pau E, González-Sancho JM, Hanniford D, Martínez N, Costales-Carrera A, Real FX, Pálmer HG, Rojas JM, Hernando E, Muñoz A (2015) SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR -150. Oncogene. doi: 10.1038/onc.2015.366
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-97.
3. Bera A, VenkataSubbaRao K, Manoharan MS, Hill P, Freeman JW (2014) A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer. PLoS ONE 9:e106343.
4. Boeri M, Pastorino U, Sozzi G (2012) Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 18:268-74.
5. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559-64.
6. Chai J, Wang S, Han D, Dong W, Xie C, Guo H (2015) MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase. Tumour Biol 36:1313-21.
7. Dong L, Deng J, Sun ZM, Pan AP, Xiang XJ, Zhang L, Yu F, Chen J, Sun Z, Feng M, Xiong JP (2015a) Interference with the beta-catenin gene in gastric cancer induces changes to the miRNA expression profile. Tumour Biol 36(9):6973-83.
8. Dong W, Yao C, Teng X, Chai J, Yang X, Li B (2015b) MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer. Tumour Biol.
9. Duan S, Tsai Y, Keng P, Chen Y, Lee SO, Chen Y (2015) IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules. Oncotarget 6:27651-60.
10. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300.
11. Ji X, Wu B, Fan J, Han R, Luo C, Wang T, Yang J, Han L, Zhu B, Wei D, Chen J, Ni C (2015) The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis. Sci Rep 5:14131.
12. Jiang J, Lv X, Fan L, Huang G, Zhan Y, Wang M, Lu H (2014) MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1. Tumour Biol 35:10019-23.
13. Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang J, Ren T (2015) MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer. Cancer Cell Int 15:84.
14. Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D (2014) As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3beta pathway. Oncogene 33:909-20.
15. Qian B, Nag SA, Su Y, Voruganti S, Qin JJ, Zhang R, Cho WC (2013) MiRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Curr Cancer Drug Targets 13:519-41.
16. Qiu G, Lin Y, Zhang H, Wu D (2015) MiR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun 463:315-21.
17. Ren P, Gong F, Zhang Y, Jiang J, Zhang H (2015) MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN. Tumour Biol 17:311-21.
18. Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, Velazquez-Torres G, Nip KM, Zhu K, Brooks D, Jones SJ, Birol I, Mosqueda M, Wen YY, Eterovic AK, Sood AK, Hwu P, Gershenwald JE, Robertson AG, Calin GA, Markel G, Fidler IJ, Bar-Eli M (2015) Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol 17:311-21.
19. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
20. Sun J, Ding W, Zhi J, Chen W (2015a) MiR-200 suppresses metastases of colorectal cancer through ZEB1. Tumour Biol. doi: 10.1007/s13277-015-3822-3
21. Sun X, Li Y, Yu J, Pei H, Luo P, Zhang J (2015b) MiR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1. Jpn J Clin Oncol 45:474-82.
22. Swingler TE, Wheeler G, Carmont V, Elliott HR, Barter MJ, Abu-Elmagd M, Donell ST, Boot-Handford RP, Hajihosseini MK, Münsterberg A, Dalmay T, Young DA, Clark IM (2012) The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 64:1909-19.
23. Takeyama Y, Sato M, Horio M, Hase T, Yoshida K, Yokoyama T, Nakashima H, Hashimoto N, Sekido Y, Gazdar AF, Minna JD, Kondo M, Hasegawa Y (2010) Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 296:216-24.
24. Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K, Nagata I, Yamashita S (2010) MiR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 296:241-8.
25. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-98.
26. Yang H, Wang Y (2015) Five miRNAs considered as molecular targets for predicting neuroglioma. Tumour Biol. doi: 10.1007/s13277-015-3898-9
27. Yang L, Yang J, Li J, Shen X, Le Y, Zhou C, Wang S, Zhang S, Xu D, Gong Z (2015) MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer. Sci Rep 5:13677.
28. Ye L, Wang H, Liu B (2015) MiR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1. Tumour Biol.
29. Yu T, Liu L, Li J, Yan M, Lin H, Liu Y, Chu D, Tu H, Gu A, Yao M (2015) MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN. Oncotarget 6:30239-50.
30. Zhang Z, Hou C, Meng F, Zhao X, Zhang Z, Huang G, Chen W, Fu M, Liao W (2015) MiR-455-3p regulates early chondrogenic differentiation via inhibiting Runx2. FEBS Lett 589(23):3671-8.